Nanopharmaceuticals – Thematic Research
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The global nanopharmaceuticals market size was US$27 billion in 2018 and is expected to grow at CAGR of more than 7% between 2018 and 2025. Nanomedicine is the application of nanotechnology for the diagnosis, prevention, and treatment of disease. It encompasses different applications including drug delivery systems, therapeutic use, imaging, diagnostics, biomaterials, and active implants.
The nanopharmaceuticals market research report will assist in developing business strategies by understanding how nanotechnology is being used in healthcare today and how this technology is expected to affect the healthcare sector in the future. The report will also help in identifying emerging industry trends to gain a competitive advantage.
For more insights on the nanopharmaceuticals market forecast, download a free report sample
Nanopharmaceuticals Market - Key Trends
The key trends that are impacting the nanopharmaceuticals market can be classified into three categories: technology trends, macroeconomic trends, and regulatory trends.
- Technology Trends – The key technology trends impacting the nanopharmaceuticals market are the use of nanomaterials in personalized/ precision medicine, and as carriers for RNAi-based therapies, development of smart nanocarriers, and nano-radio enhancers. It also includes the increasing use of immunoconjugates in nanomedicine, use of theranostic nanoparticles in cancer, and new routes of administration among others.
- Macroeconomic Trends – The key macroeconomic trends that will shape the nanopharmaceuticals market are the aging population and rise of chronic diseases, antibiotic resistance, reimbursement and cost-benefit considerations, government investment in nanomedicine and increasing M&A activities among others.
- Regulatory Trends – The key regulatory trends impacting the nanopharmaceuticals market include the lack of specific regulatory guidelines for nanomedicines, and regulation of follow-on nano-pharmaceuticals.
Nanopharmaceuticals - Industry Analysis
The global nanopharmaceuticals market size was US$27 billion in 2018 and is expected to grow at a CAGR of more than 7% between 2018 and 2025. The polymer- and nanocrystal-based nanopharmaceuticals held the largest revenue share in 2018.
The analysis of the nanopharmaceuticals industry also covers:
- Marketed nanopharmaceuticals
- Pipeline nanopharmaceuticals
- Mergers, acquisitions, and strategic alliances
- Timeline
- Case studies
Nanopharmaceuticals Market - Value Chain Analysis
The Nanopharmaceuticals industry value chain can be split into immunoconjugates, nanoparticles, and nanoemulsions.
Immunoconjugates: Immunoconjugates are targeted medicines that deliver a toxic payload to tumor cells via a linker attached to a mAb that binds to a specific target antigen expressed on cancer cells. The key layers under Immunoconjugates are Antibody-Drug Conjugates, Antibody-Radionuclide, and Antibody-Antibiotic.
Nanopharmaceuticals Market Value Chain Analysis
To know more about the nanopharmaceuticals market value chain, download a free report sample
Leading Public Companies in the Nanopharmaceuticals Market
The leading public companies in the nanopharmaceuticals market are Actinium Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc., Amgen Inc, Aurinia Pharmaceuticals Inc, AstraZeneca, Bausch Health Companies Inc, Biogen, Ipsen SA, Merck & Co Inc, Pfizer Inc, and Sanofi among others.
The leading private companies in the nanopharmaceuticals market are Horizon Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Nanospectra Biosciences Inc, Ocugen Inc, Pharmacosmos AS, and Rakuten Medical Inc among others.
Nanopharmaceuticals Market Overview
Report Pages | 96 |
Regions Covered | Global |
Market Size (2018) | $27 billion |
CAGR (2018-2025) | >7% |
Key Trends | Technology Trends, Macroeconomic Trends, and Regulatory Trends |
Value Chains | Immunoconjugates, Nanoparticles, and Nanoemulsions |
Leading Public Companies | Actinium Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc., Amgen Inc, Aurinia Pharmaceuticals Inc, AstraZeneca, Bausch Health Companies Inc, Biogen, Ipsen SA, Merck & Co Inc, Pfizer Inc, and Sanofi |
Leading Private Companies | Horizon Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Nanospectra Biosciences Inc, Ocugen Inc, Pharmacosmos AS, and Rakuten Medical Inc |
Key Highlights
The Nanopharmaceuticals report provides an assessment of the key industry trends impacting how nanopharmaceuticals are being used in healthcare today, including technological, regulatory, and macroeconomic themes.
Components of the report include:
- Key Industry Players – the big players in the nanopharmaceuticals industry and where they sit in the value chain.
- Trends in the nanopharmaceuticals space – key trends impacting the use of nanopharmaceuticals classified into technology, macroeconomic, and regulatory themes.
- Industry Analysis – the market value of marketed and pipeline nanopharmaceuticals to 2025, as well as a breakdown of nanopharmaceuticals by branded or generic product, phase of development, type of company, and route of administration. Key M&A and licensing agreements in the nanopharmaceuticals space are also included, as well as case studies showing examples of the different types of nanopharmaceuticals and their application.
- Value Chain – Leaders and challengers by nanopharmaceuticals type
Reasons to Buy
The report will help you to:
- Develop business strategies by understanding how nanotechnology is being used in healthcare today and how this technology is expected to affect the healthcare sector in the future.
- Stay up to date on the industry’s big players in nanopharmaceuticals and where they sit in the value chain.
- Identify emerging industry trends to gain a competitive advantage.
- Identify pipeline targets for M&A and licensing opportunities.
Table of Contents
Frequently asked questions
-
What was the nanopharmaceuticals market size in 2018?
The global nanopharmaceuticals market size was US$27 billion in 2018.
-
What is the nanopharmaceuticals market growth rate?
The nanopharmaceuticals market is expected to grow at a CAGR of more than 7% between 2018 and 2025.
-
What key technology trends are impacting the nanopharmaceuticals market?
The key technology trends impacting the nanopharmaceuticals market are the use of nanomaterials in personalized/ precision medicine, and as carriers for RNAi-based therapies, development of smart nanocarriers, and nano-radio enhancers. It also includes the increasing use of immunoconjugates in nanomedicine, use of theranostic nanoparticles in cancer, and new routes of administration among others.
-
What key macroeconomic trends are shaping the nanopharmaceuticals market?
The key macroeconomic trends that will shape the nanopharmaceuticals market are the aging population and rise of chronic diseases, antibiotic resistance, reimbursement and cost-benefit considerations, government investment in nanomedicine and increasing M&A activities among others.
-
What key regulatory trends are impacting the nanopharmaceuticals market?
The key regulatory trends impacting the nanopharmaceuticals market include the lack of specific regulatory guidelines for nanomedicines, and regulation of follow-on nano-pharmaceuticals.
-
What are the components of the nanopharmaceuticals industry value chains?
The nanopharmaceuticals industry value chain can be split into immunoconjugates, nanoparticles, and nanoemulsions.
-
Which are the leading public companies in the nanopharmaceuticals industry?
The leading public companies in the nanopharmaceuticals industry are Actinium Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc., Amgen Inc, Aurinia Pharmaceuticals Inc, AstraZeneca, Bausch Health Companies Inc, Biogen, Ipsen SA, Merck & Co Inc, Pfizer Inc, and Sanofi among others .
-
Which are the leading private companies in the nanopharmaceuticals industry?
The leading private companies in the nanopharmaceuticals industry are Horizon Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Nanospectra Biosciences Inc, Ocugen Inc, Pharmacosmos AS, and Rakuten Medical Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.